• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Broad Institute - Articles and news items

Broad Institute Genomic Services offers genomic insight into Ninlaro

Industry news / 25 January 2016 / Victoria White

Ninlaro (ixazomib) was recently approved by the FDA, indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma…

 

Webinar: Understanding ISO Standards: ISO 14644-2:2015 Cleanroom MonitoringFIND OUT MORE
+ +